{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:36:14Z","timestamp":1790728574721,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aim to assess the antibacterial and anti-biofilm properties of Niosome-encapsulated Imipenem. After isolating <jats:italic>Staphylococcus epidermidis<\/jats:italic> isolates and determining their microbial sensitivity, their ability to form biofilms was examined using plate microtiter assay. Various formulations of Niosome-encapsulated Imipenem were prepared using the thin-film hydration method, Minimum Biofilm Inhibitory Concentration (MBIC) and Minimum Inhibitory Concentration (MIC) were determined, and biofilm genes expression was examined. Drug formulations\u2019 toxicity effect on HDF cells were determined using MTT assay. Out of the 162 separated <jats:italic>S. epidermidis<\/jats:italic>, 106 were resistant to methicillin. 87 <jats:italic>MRSE<\/jats:italic> isolates were vancomycin-resistant, all of which could form biofilms. The F1 formulation of niosomal Imipenem with a size of 192.3\u2009\u00b1\u20095.84 and an encapsulation index of 79.36\u2009\u00b1\u20091.14 was detected, which prevented biofilm growth with a BGI index of 69% and reduced <jats:italic>icaD<\/jats:italic>, <jats:italic>FnbA<\/jats:italic>, <jats:italic>EbpS<\/jats:italic> biofilms\u2019 expression with P\u2009\u2264\u20090.001 in addition to reducing MBIC and MIC by 4\u20136 times. Interestingly, F1 formulation of niosomal Imipenem indicated cell viability over 90% at all tested concentrations. The results of the present study indicate that Niosome-encapsulated Imipenem reduces the resistance of <jats:italic>MRSE<\/jats:italic> to antibiotics in addition to increasing its anti-biofilm and antibiotic activity, and could prove useful as a new strategy for drug delivery.<\/jats:p>","DOI":"10.1038\/s41598-022-09195-9","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T07:03:59Z","timestamp":1648191839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effects of Imipenem-containing Niosome nanoparticles against high prevalence methicillin-resistant Staphylococcus Epidermidis biofilm formed"],"prefix":"10.1038","volume":"12","author":[{"given":"Tohid","family":"Piri-Gharaghie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Jegargoshe-Shirin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saremi-Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-hossein","family":"Khademhosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskandar","family":"Hoseinnezhad-lazarjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aezam","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Rajaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anali","family":"Riahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Farhadi-Biregani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadegh","family":"Fatehi-Ghahfarokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"9195_CR1","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2147\/IDR.S175014","volume":"12","author":"S Ansari","year":"2019","unstructured":"Ansari, S. et al. Recent advances in Staphylococcus aureus infection: Focus on vaccine development. Infect. Drug Resist. 12, 1243. https:\/\/doi.org\/10.2147\/IDR.S175014 (2019).","journal-title":"Infect. Drug Resist."},{"issue":"5","key":"9195_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1086\/313440","volume":"29","author":"C Gonz\u00e1lez","year":"1999","unstructured":"Gonz\u00e1lez, C. et al. \"Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin. Infect. Dis. 29(5), 1171\u20131177. https:\/\/doi.org\/10.1086\/313440 (1999).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"9195_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"17","author":"NA Turner","year":"2019","unstructured":"Turner, N. A. et al. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 17(4), 203\u2013218. https:\/\/doi.org\/10.1038\/s41579-018-0147-4 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"9195_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcimb.2020.00107","volume":"10","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol. 10, 107. https:\/\/doi.org\/10.3389\/fcimb.2020.00107 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9195_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2019.100966","volume":"29","author":"U Liebchen","year":"2020","unstructured":"Liebchen, U. et al. Therapeutic drug monitoring-guided high dose Imipenem therapy of a multidrug resistant Acinetobacter baumannii\u2014A case report. Respir. Med. Case. Rep. 29, 100966. https:\/\/doi.org\/10.1016\/j.rmcr.2019.100966 (2020).","journal-title":"Respir. Med. Case. Rep."},{"issue":"6","key":"9195_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/03079450903349212","volume":"38","author":"M Nemati","year":"2009","unstructured":"Nemati, M. et al. Screening of genes encoding adhesion factors and biofilm formation in Staphylococcus aureus isolates from poultry. Avian Pathol. 38(6), 513\u2013517. https:\/\/doi.org\/10.1080\/03079450903349212 (2009).","journal-title":"Avian Pathol."},{"issue":"12","key":"9195_CR7","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1007\/s10096-016-2763-0","volume":"35","author":"TJ Foster","year":"2016","unstructured":"Foster, T. J. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 35(12), 1923\u20131931. https:\/\/doi.org\/10.1007\/s10096-016-2763-0 (2016).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"9195_CR8","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3389\/fmicb.2020.02054","volume":"11","author":"P Speziale","year":"2020","unstructured":"Speziale, P. & Pietrocola, G. The multivalent role of fibronectin-binding proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in host infections. Front. Microbiol. 11, 2054. https:\/\/doi.org\/10.3389\/fmicb.2020.02054 (2020).","journal-title":"Front. Microbiol."},{"issue":"11","key":"9195_CR9","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.3390\/ijms19113487","volume":"19","author":"B Kot","year":"2018","unstructured":"Kot, B., Sytykiewicz, H. & Sprawka, I. Expression of the biofilm-associated genes in methicillin-resistant Staphylococcus aureus in biofilm and planktonic conditions. Int. J. Mol. Sci. 19(11), 3487. https:\/\/doi.org\/10.3390\/ijms19113487 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"9195_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2144\/fsoa-2019-0098","volume":"6","author":"AA Elshamy","year":"2020","unstructured":"Elshamy, A. A. & Aboshanab, K. P. A review on bacterial resistance to carbapenems: Epidemiology, detection and treatment options. Future Sci. OA. 6(3), 438. https:\/\/doi.org\/10.2144\/fsoa-2019-0098 (2020).","journal-title":"Future Sci. OA."},{"issue":"1","key":"9195_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jcm.2011.12.001","volume":"11","author":"BN Green","year":"2012","unstructured":"Green, B. N. et al. Methicillin-resistant Staphylococcus aureus: An overview for manual therapists. J. Chiropract. Med. 11(1), 64\u201376. https:\/\/doi.org\/10.1016\/j.jcm.2011.12.001 (2012).","journal-title":"J. Chiropract. Med."},{"issue":"12","key":"9195_CR12","doi-asserted-by":"publisher","first-page":"e01067","DOI":"10.1016\/j.heliyon.2018.e01067","volume":"4","author":"Z Khatoon","year":"2018","unstructured":"Khatoon, Z. et al. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention. Heliyon. 4(12), e01067. https:\/\/doi.org\/10.1016\/j.heliyon.2018.e01067 (2018).","journal-title":"Heliyon."},{"issue":"8","key":"9195_CR13","doi-asserted-by":"publisher","first-page":"e02192","DOI":"10.1016\/j.heliyon.2019.e02192","volume":"5","author":"G Gebreyohannes","year":"2019","unstructured":"Gebreyohannes, G. et al. Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. Heliyon. 5(8), e02192. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02192 (2019).","journal-title":"Heliyon."},{"issue":"11","key":"9195_CR14","doi-asserted-by":"publisher","first-page":"e0224904","DOI":"10.1371\/journal.pone.0224904","volume":"14","author":"R Vazquez-Mu\u00f1oz","year":"2019","unstructured":"Vazquez-Mu\u00f1oz, R. et al. Enhancement of antibiotics antimicrobial activity due to the silver nanoparticles impact on the cell membrane. PLoS ONE 14(11), e0224904. https:\/\/doi.org\/10.1371\/journal.pone.0224904 (2019).","journal-title":"PLoS ONE"},{"issue":"9","key":"9195_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/pharmaceutics11090448","volume":"11","author":"\u00c1 Martin-Serrano","year":"2019","unstructured":"Martin-Serrano, \u00c1. et al. Nanosystems as vehicles for the delivery of antimicrobial peptides (AMPs). Pharmaceutics. 11(9), 448. https:\/\/doi.org\/10.3390\/pharmaceutics11090448 (2019).","journal-title":"Pharmaceutics."},{"issue":"5","key":"9195_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/molecules25051134","volume":"25","author":"R Becerril","year":"2020","unstructured":"Becerril, R., Ner\u00edn, C. & Silva, F. Encapsulation systems for antimicrobial food packaging components: An update. Molecules 25(5), 1134. https:\/\/doi.org\/10.3390\/molecules25051134 (2020).","journal-title":"Molecules"},{"issue":"2","key":"9195_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pharmaceutics11020055","volume":"11","author":"X Ge","year":"2019","unstructured":"Ge, X. et al. Advances of nonionic surfactant vesicles (Niosomes) and their application in drug delivery. Pharmaceutics. 11(2), 55. https:\/\/doi.org\/10.3390\/pharmaceutics11020055 (2019).","journal-title":"Pharmaceutics."},{"issue":"4","key":"9195_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1515\/abm-2018-0002","volume":"11","author":"PL Yeo","year":"2018","unstructured":"Yeo, P. L. et al. Niosomes: a review of their structure, properties, methods of preparation, and medical applications. Asian Biomed. 11(4), 301\u2013314. https:\/\/doi.org\/10.1515\/abm-2018-0002 (2018).","journal-title":"Asian Biomed."},{"issue":"6","key":"9195_CR19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/nano10061191","volume":"10","author":"S Durak","year":"2020","unstructured":"Durak, S. et al. Niosomal drug delivery systems for ocular disease\u2014Recent advances and future prospects. Nanomaterials 10(6), 1191. https:\/\/doi.org\/10.3390\/nano10061191 (2020).","journal-title":"Nanomaterials"},{"key":"9195_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6365295","author":"Y-Q Xu","year":"2016","unstructured":"Xu, Y.-Q. et al. Niosome encapsulation of curcumin: Characterization and cytotoxic effect on ovarian cancer cells. J. Nanomater. https:\/\/doi.org\/10.1155\/2016\/6365295 (2016).","journal-title":"J. Nanomater."},{"issue":"3","key":"9195_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1208\/s12249-008-9105-1","volume":"9","author":"G Abdelbary","year":"2008","unstructured":"Abdelbary, G. & El-gendy, N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 9(3), 740\u2013747. https:\/\/doi.org\/10.1208\/s12249-008-9105-1 (2008).","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"9195_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3892\/br.2015.481","volume":"3","author":"W Li","year":"2015","unstructured":"Li, W., Zhou, J. & Yuyin, Xu. Study of the in vitro cytotoxicity testing of medical devices. Biomed. Rep. 3(5), 617\u2013620. https:\/\/doi.org\/10.3892\/br.2015.481 (2015).","journal-title":"Biomed. Rep."},{"key":"9195_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202100426","author":"TP Gharaghie","year":"2022","unstructured":"Gharaghie, T. P. et al. Fabrication and characterization of thymol-loaded chitosan nanogels: improved antibacterial and anti-biofilm activities with negligible cytotoxicity. Chem. Biodivers. https:\/\/doi.org\/10.1002\/cbdv.202100426 (2022).","journal-title":"Chem. Biodivers."},{"key":"9195_CR24","unstructured":"Siddiqui, A.H., & Koirala, J. Methicillin resistant Staphylococcus aureus. StatPearls. www.ncbi.nlm.nih.gov\/books\/NBK482221 (2018)."},{"key":"9195_CR25","doi-asserted-by":"publisher","unstructured":"Rahimi, F., et al. Antibiotic resistance pattern of methicillin resistant and methicillin sensitive Staphylococcus aureus isolates in Tehran, Iran. 144\u2013149. https:\/\/doi.org\/10.5812\/jjm.4896 (2013).","DOI":"10.5812\/jjm.4896"},{"key":"9195_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/vms3.754","author":"S Beiranvand","year":"2022","unstructured":"Beiranvand, S. et al. Novel NAD-independent Avibacterium paragallinarum: Isolation, characterization and molecular identification in Iran. Vet. Med. Sci. https:\/\/doi.org\/10.1002\/vms3.754 (2022).","journal-title":"Vet. Med. Sci."},{"issue":"4","key":"9195_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/antibiotics9040156","volume":"9","author":"MEA Bissong","year":"2020","unstructured":"Bissong, M. E. A. & Ateba, C. N. Genotypic and phenotypic evaluation of biofilm production and antimicrobial resistance in Staphylococcus aureus isolated from Milk, North West Province. South Africa. Antibiotics. 9(4), 156. https:\/\/doi.org\/10.3390\/antibiotics9040156 (2020).","journal-title":"South Africa. Antibiotics."},{"issue":"4","key":"9195_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.29252\/sjimu.26.4.175","volume":"26","author":"T Piri Gharaghie","year":"2018","unstructured":"Piri Gharaghie, T. & Shandiz, S. A. S. The inhibitory effects of silver nanoparticles on bap gene expression in antibiotic-resistant acientobacter bumanni isolates using real-time PCR. Sci. J. Ilam Univ. Med. Sci. 26(4), 175\u2013185. https:\/\/doi.org\/10.29252\/sjimu.26.4.175 (2018).","journal-title":"Sci. J. Ilam Univ. Med. Sci."},{"issue":"4","key":"9195_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.11648\/j.ejcbs.20160206.16","volume":"9","author":"MEA Bissong","year":"2020","unstructured":"Bissong, M. E. A. & Ateba, C. N. Genotypic and Phenotypic Evaluation of Biofilm Production and Antimicrobial Resistance in Staphylococcus aureus Isolated from Milk, North West Province. South Africa. Antibiotics 9(4), 156. https:\/\/doi.org\/10.11648\/j.ejcbs.20160206.16 (2020).","journal-title":"South Africa. Antibiotics"},{"key":"9195_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/RRTD.S64773","volume":"4","author":"R Muzzalupo","year":"2015","unstructured":"Muzzalupo, R. & Tavano, L. Niosomal drug delivery for transdermal targeting: Recent advances. Res. Rep. Transderm. Drug Delivery 4, 23. https:\/\/doi.org\/10.2147\/RRTD.S64773 (2015).","journal-title":"Res. Rep. Transderm. Drug Delivery"},{"key":"9195_CR31","doi-asserted-by":"publisher","first-page":"9777","DOI":"10.2147\/IJN.S230269","volume":"14","author":"S Sadeghi","year":"2019","unstructured":"Sadeghi, S. et al. Synergistic anti-staphylococcal activity of niosomal recombinant lysostaphin-LL-37. Int. J. Nanomed. 14, 9777. https:\/\/doi.org\/10.2147\/IJN.S230269 (2019).","journal-title":"Int. J. Nanomed."},{"key":"9195_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.isci.2018.12.025","volume":"11","author":"W Wei","year":"2019","unstructured":"Wei, W., Bai, F. & Fan, H. Surfactant-assisted cooperative self-assembly of nanoparticles into active nanostructures. IScience. 11, 272\u2013293. https:\/\/doi.org\/10.1016\/j.isci.2018.12.025 (2019).","journal-title":"IScience."},{"issue":"7","key":"9195_CR33","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3109\/02652048.2010.506579","volume":"27","author":"E Moazeni","year":"2010","unstructured":"Moazeni, E. et al. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. J. Microencapsul. 27(7), 618\u2013627. https:\/\/doi.org\/10.3109\/02652048.2010.506579 (2010).","journal-title":"J. Microencapsul."},{"issue":"2","key":"9195_CR34","first-page":"69","volume":"7","author":"V Akbari","year":"2015","unstructured":"Akbari, V. et al. Release studies on ciprofloxacin loaded nonionic surfactant vesicles. Avicenna J. Med. Biotechnol. 7(2), 69 (2015).","journal-title":"Avicenna J. Med. Biotechnol."},{"key":"9195_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-5173(02)00301-0","volume":"1","author":"Y Hao","year":"2002","unstructured":"Hao, Y. et al. Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 1, 73\u201380. https:\/\/doi.org\/10.1016\/S0378-5173(02)00301-0 (2002).","journal-title":"Int. J. Pharm."},{"issue":"9","key":"9195_CR36","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.2174\/1567201815666180619105419","volume":"15","author":"DE Aziz","year":"2018","unstructured":"Aziz, D. E., Abdelbary, A. A. & Elassasy, A. I. Implementing central composite design for developing transdermal diacerein-loaded Niosomes: Ex vivo permeation and in vivo deposition. Curr. Drug Delivery 15(9), 1330\u20131342. https:\/\/doi.org\/10.2174\/1567201815666180619105419 (2018).","journal-title":"Curr. Drug Delivery"},{"issue":"12","key":"9195_CR37","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3390\/nano11123391","volume":"11","author":"T Limongi","year":"2021","unstructured":"Limongi, T. et al. Lipid-based nanovesicular drug delivery systems. Nanomaterials 11(12), 3391. https:\/\/doi.org\/10.3390\/nano11123391 (2021).","journal-title":"Nanomaterials"},{"issue":"4","key":"9195_CR38","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"KM Kazi","year":"2010","unstructured":"Kazi, K. M. et al. Niosome: A future of targeted drug delivery systems. J. Adv. Pharm. Technol. Res. 1(4), 374. https:\/\/doi.org\/10.4103\/0110-5558.76435 (2010).","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"10","key":"9195_CR39","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1081\/DDC-120015351","volume":"28","author":"A Balasubramaniam","year":"2002","unstructured":"Balasubramaniam, A., Anil Kumar, V. & Sadasivan Pillai, K. Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev. Ind. Pharm. 28(10), 1181\u20131193. https:\/\/doi.org\/10.1081\/DDC-120015351 (2002).","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"9195_CR40","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1208\/s12249-014-0141-8","volume":"15","author":"HS Barakat","year":"2014","unstructured":"Barakat, H. S. et al. Vancomycin-eluting niosomes: A new approach to the inhibition of staphylococcal biofilm on abiotic surfaces. AAPS Pharm. Sci. Tech. 15(5), 1263\u20131274. https:\/\/doi.org\/10.1208\/s12249-014-0141-8 (2014).","journal-title":"AAPS Pharm. Sci. Tech."},{"issue":"1","key":"9195_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10371-5","volume":"7","author":"M Vallieres","year":"2017","unstructured":"Vallieres, M. et al. \"Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer. Sci. Rep. 7(1), 1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-10371-5 (2017).","journal-title":"Sci. Rep."},{"issue":"5","key":"9195_CR42","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1021\/acs.molpharmaceut.8b01256","volume":"16","author":"RM Derbali","year":"2019","unstructured":"Derbali, R. M. et al. Tailored nanocarriers for the pulmonary delivery of levofloxacin against Pseudomonas aeruginosa: A comparative study. Mol. Pharm. 16(5), 1906\u20131916. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01256 (2019).","journal-title":"Mol. Pharm."},{"key":"9195_CR43","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.2147\/IJN.S121956","volume":"12","author":"L Wang","year":"2017","unstructured":"Wang, L., Chen, Hu. & Shao, L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int. J. Nanomed. 12, 1227. https:\/\/doi.org\/10.2147\/IJN.S121956 (2017).","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"9195_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.foodres.2010.12.011","volume":"44","author":"P Kopermsub","year":"2011","unstructured":"Kopermsub, P., Mayen, V. & Warin, C. Potential use of Niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement. Food Res. Int. 44(2), 605\u2013612. https:\/\/doi.org\/10.1016\/j.foodres.2010.12.011 (2011).","journal-title":"Food Res. Int."},{"key":"9195_CR45","doi-asserted-by":"publisher","unstructured":"Theansungnoen, T., et al. Formulation and evaluation of niosomes encapsulated with KT2 and RT2: Antimicrobial and anticancer peptides derived from crocodile leukocyte extract. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.11(2).623-30 (2017).","DOI":"10.13040\/IJPSR.0975-8232.11(2).623-30"},{"issue":"4","key":"9195_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-013-1556-y","volume":"15","author":"V Akbari","year":"2013","unstructured":"Akbari, V. et al. Ciprofloxacin nano-niosomes for targeting intracellular infections: An in vitro evaluation. J. Nanopart. Res. 15(4), 1\u201314. https:\/\/doi.org\/10.1007\/s11051-013-1556-y (2013).","journal-title":"J. Nanopart. Res."},{"issue":"14","key":"9195_CR47","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1039\/C8RA09655D","volume":"9","author":"ND Machado","year":"2019","unstructured":"Machado, N. D. et al. Niosomes encapsulated in biohydrogels for tunable delivery of phytoalexin resveratrol. RSC Adv. 9(14), 7601\u20137609. https:\/\/doi.org\/10.1039\/C8RA09655D (2019).","journal-title":"RSC Adv."},{"issue":"3","key":"9195_CR48","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1208\/s12249-017-0945-4","volume":"19","author":"PV Gupta","year":"2018","unstructured":"Gupta, P. V., Nirwane, A. M. & Nagarsenker, M. S. Inhalable levofloxacin liposomes complemented with lysozyme for treatment of pulmonary infection in rats: Effective antimicrobial and antibiofilm strategy. AAPS Pharm. Sci. Tech. 19(3), 1454\u20131467. https:\/\/doi.org\/10.1208\/s12249-017-0945-4 (2018).","journal-title":"AAPS Pharm. Sci. Tech."},{"key":"9195_CR49","doi-asserted-by":"publisher","unstructured":"Manandhar, Sarita, et al. \"Evaluation of methods to detect in vitro biofilm formation by staphylococcal clinical isolates.\" BMC research notes. 11.1, 1\u20136. https:\/\/doi.org\/10.1186\/s13104-018-3820-9 (2018).","DOI":"10.1186\/s13104-018-3820-9"},{"issue":"6","key":"9195_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.micpath.2009.09.011","volume":"47","author":"A Ikonomidis","year":"2009","unstructured":"Ikonomidis, A. et al. Association of biofilm formation and methicillin-resistance with accessory gene regulator (agr) loci in Greek Staphylococcus aureus clones. Microbial Pathog. 47(6), 341\u2013344. https:\/\/doi.org\/10.1016\/j.micpath.2009.09.011 (2009).","journal-title":"Microbial Pathog."},{"issue":"8","key":"9195_CR51","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s11999-010-1266-z","volume":"468","author":"MC Lawson","year":"2010","unstructured":"Lawson, M. C. et al. Inhibition of Staphylococcus Epidermidis biofilms using polymerizable vancomycin derivatives. Clin. Orthop. Relat. Res. 468(8), 2081\u20132091. https:\/\/doi.org\/10.1007\/s11999-010-1266-z (2010).","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"2","key":"9195_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1517\/17425247.2014.942639","volume":"12","author":"AA Abdelaziz","year":"2015","unstructured":"Abdelaziz, A. A. et al. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: in vitro and in vivo evaluation. Expert Opin. Drug Delivery. 12(2), 163\u2013180. https:\/\/doi.org\/10.1517\/17425247.2014.942639 (2015).","journal-title":"Expert Opin. Drug Delivery."},{"issue":"8","key":"9195_CR53","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1021\/acs.biomac.0c00760","volume":"21","author":"Y Zhong","year":"2020","unstructured":"Zhong, Y. et al. Natural polymer-based antimicrobial hydrogels without synthetic antibiotics as wound dressings. Biomacromol 21(8), 2983\u20133006. https:\/\/doi.org\/10.1021\/acs.biomac.0c00760 (2020).","journal-title":"Biomacromol"},{"issue":"4","key":"9195_CR54","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/cbdd.12786","volume":"88","author":"D Poy","year":"2016","unstructured":"Poy, D. et al. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: An in vitro study. Chem. Biol. Drug Des. 88(4), 568\u2013573. https:\/\/doi.org\/10.1111\/cbdd.12786 (2016).","journal-title":"Chem. Biol. Drug Des."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09195-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:04:25Z","timestamp":1669338265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09195-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9195"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09195-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"assertion":[{"value":"15 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5140"}}